Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Joana Assis"'
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: The Precision Oncology Platform (POP) trial represents the effort of the Portuguese Oncology Institute of Porto (IPO Porto) for joining other leading European institutions in both ‘Personalised Cancer Medicine for all EU cit
Externí odkaz:
https://doaj.org/article/5032910dc9e843a785a1d4c043032499
Autor:
Valéria Tavares, Joana Savva-Bordalo, Mariana Rei, Joana Liz-Pimenta, Joana Assis, Deolinda Pereira, Rui Medeiros
Publikováno v:
Biomolecules, Vol 14, Iss 8, p 928 (2024)
Ovarian cancer (OC) is a leading cause of death among gynaecological malignancies. The haemostatic system, which controls blood flow and prevents clotting disorders, paradoxically drives OC progression while increasing the risk of venous thromboembol
Externí odkaz:
https://doaj.org/article/ebd3edaa75704283ac3fb0f32a032214
Publikováno v:
Molecular and Cellular Probes, Vol 70, Iss , Pp 101917- (2023)
Ischaemic stroke (IS) and venous thromboembolism (VTE) are two forms of thromboembolism that, although distinct, seem to share numerous risk factors. Concerning genetic risk factors, while many VTE genetic markers have been reported, inclusively by g
Externí odkaz:
https://doaj.org/article/0fae77ed6e8d4034be656a08d0390aae
Autor:
Valéria Tavares, Inês Soares Marques, Inês Guerra de Melo, Joana Assis, Deolinda Pereira, Rui Medeiros
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 3, p 1845 (2024)
Ovarian cancer (OC) is the female genital malignancy with the highest lethality. Patients present a poor prognosis mainly due to the late clinical presentation allied with the common acquisition of chemoresistance and a high rate of tumour recurrence
Externí odkaz:
https://doaj.org/article/6c33eef62b6c404796a8157ddc72c3f6
Autor:
Inês Soares Marques, Valéria Tavares, Joana Savva-Bordalo, Mariana Rei, Joana Liz-Pimenta, Inês Guerra de Melo, Joana Assis, Deolinda Pereira, Rui Medeiros
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 140 (2023)
Ovarian cancer (OC) and venous thromboembolism (VTE) have a close relationship, in which tumour cells surpass the haemostatic system to drive cancer progression. Long non-coding RNAs (lncRNAs) have been implicated in VTE pathogenesis, yet their roles
Externí odkaz:
https://doaj.org/article/3123e73fb8e247a18956aa8895d1e91a
Publikováno v:
Data in Brief, Vol 30, Iss , Pp 105399- (2020)
Venous thromboembolism (VTE) is a common cardiovascular disease, for which several single nucleotide polymorphisms (SNPs) underlying susceptibility were identified. Apart from candidate gene approach, genome-wide association studies (GWAS) have contr
Externí odkaz:
https://doaj.org/article/dabca1e861144ad48124ab706e277ccd
Autor:
Ana L Teixeira, Mónica Gomes, Augusto Nogueira, Andreia S Azevedo, Joana Assis, Francisca Dias, Juliana I Santos, Francisco Lobo, António Morais, Joaquina Maurício, Rui Medeiros
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72419 (2013)
Prostate cancer (PC) is the most frequently diagnosed cancer in men. The acquisition of castration-resistant (CR) phenotype is associated with the activation of signaling pathways mediated by growth factors. The TGFβ1 and its receptors have an impor
Externí odkaz:
https://doaj.org/article/2320ca9fc7ed448495322603bfef8f0d
Autor:
Ana L. Teixeira, Mónica Gomes, Augusto Nogueira, Andreia S. Azevedo, Joana Assis, Francisca Dias, Juliana I. Santos, Francisco Lobo, António Morais, Joaquina Maurício, Rui Medeiros
Publikováno v:
PLoS ONE, Vol 8, Iss 8 (2013)
Externí odkaz:
https://doaj.org/article/118126ac7b8f42db9a39469865261987
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
José Pedro L. Nunes, Margarida Freitas-Silva, Márcia Ferreira, Joana Assis, Ricardo Pinto, Rui Medeiros
Publikováno v:
Pharmacogenomics. 21(2)
Despite the clinical benefits of aspirin, the interindividual variation in response to this antiplatelet drug is considerable. The manifestation of aspirin resistance (AR) is frequently observed, although this complex process remains poorly understoo